12. Sep 2022
schülke, a leading global provider of infection prevention and hygiene solutions in healthcare, acquires Spanish company Vesismin Health, expert in infection control in the hospital sector
Norderstedt, 12. September 2022. schülke Group, a leading global provider in the fields of infection prevention and hygiene solutions in healthcare, announces the acquisition of the Spanish company Vesismin Health (VESISMIN, S.L.), based in Barcelona. Vesismin Health's mission – which is a perfect match to the schülke mission ’we protect lives worldwide’ – is to develop and promote innovative disinfectants, with a proven specialization in hospital infection control. The company provides market-leading chlorhexidine-based antiseptics, surface disinfectants, high-level disinfection solutions for medical devices and equipment based on the most advanced technologies. With this strategic acquisition, schülke strengthens its presence in Southern Europe – primarily Spain, France, Portugal – and creates synergies in the areas of research & development, sourcing and complements perfectly the existing product portfolio of schülke. Vesismin Health also offers with Vesismin UV a technology that provides advanced disinfection with ultraviolet light. Vesismin UV is designed to achieve high efficiency in hospital disinfection.
schülke already has more than 1,100 dedicated employees, over 20 subsidiaries and three production sites in Germany (schülke), France (Bioxal) and Brazil (Vic Pharma). People in more than 80 countries around the world rely on schülke's infection prevention and hygiene solutions every day. Following the acquisition of the Danish company Wet Wipe A/S in early July 2022 and the associated expansion into the Scandinavian market, schülke is now further extending its reach as well as its product portfolio in Southern Europe.
Stefan Kukacka, CEO of schülke, explains, "The acquisition once again underlines our ambitious growth strategy and our mission 'to protect lives worldwide'. With Vesismin Health, we are expanding the schülke Group with a high-profile company for infection prevention and hygiene solutions in healthcare. Based on Vesismin Health's expertise in formulations with the active ingredient chlorhexidine, we will together create a center of excellence for chlorhexidine-based products. We are very much looking forward to working together and sharing our experiences and joint innovations!"
Víctor Vallés, Founder and CEO of Vesismin Health: "We are very pleased to become part of the schülke Group, which has long-standing experience as a global supplier in the field of infection prevention and hygiene solutions. This union strengthens our position, broadens our current product range and turns us into the supplier with the most extensive range of infection prevention products. The agreement with the schülke Group will permit us to further develop our expertise in chlorhexidine-based products, as well as to continue to maintain our profile as an innovative company. Vesismin Health will continue as an independent company within the group and will maintain its current team of professionals. This collaboration will allow us to grow both in the Spanish market and in other markets and to take another step forward in our commitment and our raison d'être: the daily fight against hospital-acquired infections.”
Schülke & Mayr GmbH has been a global leader in infection prevention and hygiene control for more than 130 years. With its wide range of high-quality and innovative products, expert advice and reliable service, schülke offers holistic concepts for infection prevention in professional healthcare markets, consumers and in the pharmaceutical sector. Committed to our mission of protecting lives worldwide, we actively contribute to the safety and protection of human health in our strategic business areas of Healthcare, Over the Counter (OTC) and Industrial Hygiene. Infectious agents know no borders - this is gaining even more importance in today's globalized world. schülke is present with more than 1,100 dedicated employees, over 20 subsidiaries and three production sites in Germany (schülke), France (Bioxal) and Brazil (Vic Pharma). People in more than 80 countries around the world rely on our products every day. www.schuelke.de
Vesismin Health was founded in Barcelona in 2004 by entrepreneur Víctor Vallés as a project incubated at IQS University Center. Since then, the company's main goal has been to collaborate with hospitals and health centers in the fight against infectious diseases by providing effective, innovative disinfection solutions. Vesismin Health was also the first provider in Spain to formulate and launch orange chlorhexidine as an alternative to povidone-iodine to facilitate antisepsis in the surgical field and to reduce infections. The company is currently present at over 400 hospitals in Spain and is expanding into other markets such as pharmaceuticals.